TCM
TGTX icon

Tradewinds Capital Management’s TG Therapeutics TGTX Stock Holding History

Tradewinds Capital Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.8K Buy
+51
New +$2.09K ﹤0.01% 536

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Tradewinds Capital Management's TGTX Position: Q2 2026 in Review

Tradewinds Capital Management opened a new position in TG Therapeutics (TGTX) in Q2 2026: 51 shares worth $2.8K. The stake represents ﹤0.01% of the portfolio and ranks #536 among its holdings.

427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Tradewinds Capital Management held 51 shares of TG Therapeutics worth $2.8K as of Q2 2026.
  • TG Therapeutics was a new Tradewinds Capital Management position in Q2 2026.
  • TG Therapeutics made up ﹤0.01% of Tradewinds Capital Management's portfolio in Q2 2026, its #536 holding.
  • 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Tradewinds Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.